KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Lam Research (LRCX) over the last 16 years, with Q4 2025 value amounting to $2.3 billion.

  • Lam Research's Accumulated Expenses rose 818.22% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 818.22%. This contributed to the annual value of $2.4 billion for FY2025, which is 3288.18% up from last year.
  • According to the latest figures from Q4 2025, Lam Research's Accumulated Expenses is $2.3 billion, which was up 818.22% from $2.4 billion recorded in Q3 2025.
  • In the past 5 years, Lam Research's Accumulated Expenses registered a high of $2.4 billion during Q3 2025, and its lowest value of $1.3 billion during Q1 2021.
  • For the 5-year period, Lam Research's Accumulated Expenses averaged around $2.0 billion, with its median value being $2.0 billion (2023).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 3510.99% in 2021, then tumbled by 1038.28% in 2024.
  • Over the past 5 years, Lam Research's Accumulated Expenses (Quarter) stood at $1.8 billion in 2021, then grew by 16.83% to $2.1 billion in 2022, then fell by 4.47% to $2.0 billion in 2023, then grew by 6.08% to $2.1 billion in 2024, then rose by 8.18% to $2.3 billion in 2025.
  • Its Accumulated Expenses was $2.3 billion in Q4 2025, compared to $2.4 billion in Q3 2025 and $2.4 billion in Q2 2025.